MASTOCYTIC LEUKAEMIA

MASTOCYTIC LEUKAEMIA was reported 19 times

MASTOCYTIC LEUKAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
1 Anti-anginal [EPC] 1 0.0001
2 Vasopressin V2 Receptor Antagonist [EPC] 1 0.0001
3 Histamine-1 Receptor Antagonist [EPC] 2 0.0000
4 Kinase Inhibitor [EPC] 8 0.0000
5 Purine Antimetabolite [EPC] 1 0.0000
6 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
7 Microtubule Inhibitor [EPC] 1 0.0000
8 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
9 Platinum-based Drug [EPC] 1 0.0000
10 Proton Pump Inhibitor [EPC] 2 0.0000
11 Loop Diuretic [EPC] 1 0.0000
12 Corticosteroid [EPC] 1 0.0000